CAS: 13522-14-0 - 3β-hydroxy-2β,16β-dipiperidino-5-α-androstan-17-one
Formel:C29H48N2O2
InChl:InChI=1S/C29H48N2O2/c1-28-12-11-22-21(23(28)18-24(27(28)33)30-13-5-3-6-14-30)10-9-20-17-26(32)25(19-29(20,22)2)31-15-7-4-8-16-31/h20-26,32H,3-19H2,1-2H3/t20-,21+,22-,23-,24-,25-,26-,28-,29-/m0/s1
InChI Key:InChIKey=KUCISTFXMDQUHG-XMTFRXHISA-N
SMILES:O=C1C(N2CCCCC2)CC3C4CCC5CC(O)C(N6CCCCC6)CC5(C)C4CCC13C
- Synonyme:
- (2Beta,3Alpha,5Alpha,16Beta)-3-Hydroxy-2,16-Di(Piperidin-1-Yl)Androstan-17-One
- (2β,3α,5α,16β)-3-Hydroxy-2,16-di-1-piperidinylandrostan-17-one
- 2β,16β-Dipiperidino-5α-androstan-3α-ol-17-one
- 3beta-Hydroxy-2beta,16beta-dipiperidino-5-alpha-androstan-17-one
- 5α-Androstan-17-one, 3β-hydroxy-2β,16β-dipiperidino-
- Androstan-17-one,3-hydroxy-2,16-di-1-piperidinyl-, (2b,3a,5a,16b)-
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
Androstan-17-one, 3-hydroxy-2,16-di-1-piperidinyl-,(2,3,5,16)-(9CI) REF: IN-DA009F3XCAS: 13522-14-0 | 98% | Nachfragen | Di 07 Jan 25 | |
Vecuronium Bromide Impurity 1 REF: 4Z-V-069007CAS: 13522-14-0 | - - - | Nachfragen | Di 07 Jan 25 | |
2β,16β-Dipiperidino-5α-androstan-3α-ol-17-one REF: TR-D492025CAS: 13522-14-0 | - - - | 283,00 €~1.936,00 € | Fr 24 Jan 25 | |
2β,16β-Dipiperidino-5α-androstan-3α-ol-17-one REF: 3D-NAA52214CAS: 13522-14-0 | Min. 95% | - - - | Ausgelaufenes produkt |
Androstan-17-one, 3-hydroxy-2,16-di-1-piperidinyl-,(2,3,5,16)-(9CI)
Ref: IN-DA009F3X
1g | Nachfragen | ||
50mg | 152,00 € | ||
250mg | 590,00 € |
Ref: 4Z-V-069007
10mg | Nachfragen | ||
25mg | Nachfragen | ||
50mg | Nachfragen | ||
100mg | Nachfragen |
2β,16β-Dipiperidino-5α-androstan-3α-ol-17-one
Kontrolliertes ProduktRef: TR-D492025
50mg | 283,00 € | ||
500mg | 1.936,00 € |
2β,16β-Dipiperidino-5α-androstan-3α-ol-17-one
Ref: 3D-NAA52214
5mg | Ausgelaufen | Anforderung von Informationen | |
10mg | Ausgelaufen | Anforderung von Informationen | |
25mg | Ausgelaufen | Anforderung von Informationen | |
50mg | Ausgelaufen | Anforderung von Informationen | |
100mg | Ausgelaufen | Anforderung von Informationen |